June 08th: Awshad, the pioneering medical cannabis wellness startup, has launched its latest premium offering, Calmagummies Gold, at a time when India’s wellness market is witnessing a sharp rise in demand for convenient, lifestyle-oriented nutraceutical products. Positioned around stress relief, relaxation and sleep recovery, the CBD+THC infused gummies are aimed at urban consumers in the age group of 25+ navigating high-stress lifestyles, irregular sleep cycles and growing interest in plant-based wellness solutions.
The launch comes amid rising conversations around burnout, sleep deprivation and mental wellness among India’s working professionals, especially in metro cities where consumers are increasingly spending on preventive and experience-led wellness categories instead of traditional supplements. According to a recent Grand View Research report, India’s gummy market is projected to grow at a CAGR of 17.4 per cent between 2024 and 2030, while CBD and cannabinoid-infused gummies are expected to witness even faster adoption among younger consumers seeking relaxation and mental wellness support. India’s nutraceutical market, currently estimated at nearly USD 39 billion, is also projected to more than double over the next decade, signalling a strong shift towards functional wellness products and alternative recovery formats.
Building on the strong consumer response to its existing Calmagummies range, Awshad has introduced Calmagummies Gold to cater to the increasing demand for accessible wellness formats.
Awshad Calmagummies Gold combines CBD and THC extracts with citrus botanicals and antioxidant ingredients including orange rind, lemon rind and goji berries in a chewable gummy format designed to support mood elevation, deep relaxation and restorative sleep. The formulation has been developed to offer a smoother, more controlled and approachable wellness experience for both regular users and cannabis-curious consumers. Each pack contains 10 gummies and has been positioned as a premium wellness indulgence category rather than a conventional supplement product.
“Over the last few years, we have seen a visible shift in how consumers approach wellness. People today are looking for solutions that fit naturally into their lifestyle while also addressing concerns like stress, burnout and sleep issues. In 2026, we have witnessed a notable increase in demand for sleep and relaxation related wellness products, particularly in lifestyle-friendly formats such as gummies that are easy to incorporate into daily routines.
With Calmagummies Gold, we wanted to create a product that moves beyond functionality and offers a more refined, calming and approachable experience for our modern consumers. We have also worked on making the product more palatable” said Richa Jaggi, Co-founder and CMO at Awshad.
Mr. Shivam Singhee, CEO at Awshad, said, “The cannabis wellness category in India is steadily moving beyond early adoption and entering a phase of greater consumer acceptance. We are seeing growing interest from consumers who are actively seeking science-backed, plant-based solutions that support everyday concerns such as stress management, sleep recovery and overall well-being. As awareness around medical cannabis continues to improve, consumers are becoming more informed about the role cannabinoids can play within a broader wellness routine”.
The growing consumer trust in the category is also reflected in Awshad’s customer behaviour, with repeat customers accounting for 44 per cent of the brand’s overall customer base, highlighting sustained interest in cannabis-based wellness solutions
The launch highlights the growing shift towards convenient and experience-led wellness formats among urban consumers in India. With increasing conversations around stress management, sleep wellness and preventive self-care, gummies are steadily emerging as a preferred category within the broader nutraceutical and alternative wellness market.